heading@HQ City@HQ Country@Founding Year@Website URL@Public/Private@Established/Startup@Specialty@Acquisition@# drugs@# Preclinical drugs@# Phase 1 drugs@# Phase 2 drugs@# Phase 3 drugs@# Approved drugs@# Undisclosed drugs@# trials@# Phase 1 trials@# Phase 2 trials@# Phase 3 trials@# co-developers@co-developers@# locations
3SBIO@Shenyang@China@1993@http://www.3sbio.com/@Public@Established@-@-@1@0@1@0@0@0@0@0@0@0@0@1@Alteogen@1
A&G@-@-@-@-@-@-@-@-@1@0@0@0@0@0@1@1@1@0@0@0@@0
ADC Therapeutics@Lausanne@Switzerland@2011@https://adctherapeutics.com@Public@Startup@ADC platform technology@-@10@3@3@3@0@1@0@4@1@2@1@4@Genmab | Regeneron | MedImmune | AstraZeneca@7
AGO Research@-@-@-@-@-@-@-@-@0@0@0@0@0@0@0@1@0@1@0@0@@0
ALX Oncology@Burlingame@United States@2015@https://www.alxoncology.com@Public@Startup@-@-@0@0@0@0@0@0@0@0@0@0@0@0@@0
AbGenomics BV@Oss@Netherlands@2009@https://www.abgenomics.com@Private@Startup@Unclear@-@3@1@1@0@0@0@1@0@0@0@0@0@@0
AbbVie@North Chicago@United States@2013@https://www.abbvie.com@Public@Established@Antibody developer@-@20@0@7@8@3@0@2@23@9@8@6@8@Genmab | Stemcentrx | CytomX | Roche | Genentech | EuPAL | Pfizer | Radiation Therapy Oncology Group@47
Abbott Diabetes Care@Alameda@United States@1888@https://www.abbott.com/diabetes-care.html@Public@Established@-@-@0@0@0@0@0@0@0@1@0@0@0@0@@0
Acepodia Biotech@Milpitas@United States@2016@https://www.acepodia.com@Private@Startup@-@-@0@0@0@0@0@0@0@2@2@0@0@0@@0
Actinium@New York City@United States@1971@https://www.actiniumpharma.com@Public@Established@-@-@0@0@0@0@0@0@0@0@0@0@0@0@@0
Active Biotech AB@Lund@Sweden@1983@https://www.activebiotech.com/@Public@Established@-@-@1@0@0@0@1@0@0@3@2@0@1@0@@9
Adcentrx@-@-@-@-@-@-@-@-@1@0@1@0@0@0@0@1@1@0@0@0@@1
Adimab@Lebanon@United States@2007@https://www.adimab.com@Private@Startup@Antibody developer@-@0@0@0@0@0@0@0@0@0@0@0@0@@0
Adolor Corp@Exton@United States@1994@-@-@Established@-@Acquired by Cubist Pharmaceuticals in 2011@1@1@0@0@0@0@0@0@0@0@0@0@@0
Affinicon@-@-@-@-@-@-@-@-@1@0@0@0@1@0@0@0@0@0@0@0@@35
Agensys@Santa Monica@United States@1996@-@Private@Startup@Antibody developer@Acquired by Astellas in 2007@4@0@4@0@0@0@0@1@1@0@0@3@Astellas | Ligand Pharmaceuticals | Seagen@1
Aivita Biomedical@Irvine@United States@2016@https://aivitabiomedical.com@Private@Startup@-@-@0@0@0@0@0@0@0@4@2@1@1@1@PT AIVITA Biomedika Indonesia@0
Alaunos Therapeutics@Houston@United States@1992@https://www.alaunos.com@Public@Established@-@-@0@0@0@0@0@0@0@1@1@0@0@0@@0
Alethia@-@-@-@-@-@-@-@-@1@0@0@0@0@0@1@0@0@0@0@0@@0
Alfasigma@Bologna@Italy@1948@https://www.alfasigma.com/@Private@Established@-@-@1@1@0@0@0@0@0@0@0@0@0@0@@0
Alliance Foundation Trials@New York City@United States@-@https://www.alliancefoundationtrials.org@Non-profit@Established@-@-@0@0@0@0@0@0@0@3@0@1@2@6@NSABP Foundation | Genentech | Eli Lilly | Seagen | GILEAD | Pfizer@0
Alligator Bioscience AB@Lund@Sweden@2001@https://www.alligatorbioscience.com@Public@Startup@Antibody developer@-@4@2@0@0@2@0@0@2@1@0@1@0@@4
Almac Discovery@Craigavon@UK@2001@https://www.almacgroup.com@Private@Startup@Unclear@-@2@2@0@0@0@0@0@0@0@0@0@0@@0
Alphamab Oncology@Suzhou@China@2011@https://www.alphamaboncology.com/@Public@Startup@Antibody Developer@-@1@0@1@0@0@0@0@1@1@0@0@0@@1
Alteogen@Daejeon@South Korea@2008@https://www.alteogen.com@Public@Startup@Unclear@-@2@1@1@0@0@0@0@1@1@0@0@1@3SBIO@1
Alzamend Neuro@Tampa@United States@2016@https://www.alzamend.com@Public@Startup@-@-@0@0@0@0@0@0@0@1@0@1@0@1@bioRASI, LLC@0
Ambrx@La Jolla@United States@2003@https://www.ambrx.com@Private@Startup@ADC platform technology@-@7@4@0@3@0@0@0@4@2@2@0@2@Progenics Pharmaceuticals | Johnson & Johnson@5
Amgen@Thousand Oaks@United States@1980@https://www.amgen.com@Public@Established@Antibody developer@-@5@0@4@0@1@0@0@4@2@1@1@6@DAIICHI SANKYO | Servier | GlaxoSmithKline | Nova Laboratories Limited | NordForsk | Pfizer@10
Amphera BV@Leiden@Netherlands@-@https://www.amphera.nl@Private@-@-@-@0@0@0@0@0@0@0@1@0@0@1@1@TMC Pharma@0
Amsterdam UMC@Amsterdam@Netherlands@-@https://www.amsterdamumc.org@Public@Established@-@-@0@0@0@0@0@0@0@1@0@0@0@0@@0
Angiex@Cambridge@United States@2015@https://www.angiex.com@Private@Startup@Unclear@-@2@1@1@0@0@0@0@1@1@0@0@1@Pfizer@1
Antengene@Shanghai@China@2017@https://www.antengene.com/@Public@Startup@Antibody Developer@-@1@0@1@0@0@0@0@0@0@0@0@0@@0
AntibodyChem Biosciences@-@-@-@-@-@-@-@-@1@0@0@1@0@0@0@1@0@1@0@1@Legochem@2
Apices Soluciones S.L@Madrid@Spain@-@https://www.apices.es@Private@-@-@-@0@0@0@0@0@0@0@1@0@1@0@0@@0
Arcus@Hayward@United States@2015@https://www.arcusbio.com/@Public@Startup@Antibody Developer@-@0@0@0@0@0@0@0@2@0@2@0@1@GILEAD@0
Argenta Discovery Ltd@Harlow@UK@2000@https://www.argentadiscovery.com@Private@Established@Unclear@-@3@2@0@1@0@0@0@0@0@0@0@0@@0
Array BioPharma@Boulder@United States@1998@-@Public@Established@-@Acquired by Pfizer in 2019@0@0@0@0@0@0@0@1@0@1@0@2@GILEAD | Pfizer@0
Arterica@-@-@-@-@-@-@-@-@0@0@0@0@0@0@0@1@0@0@0@0@@0
Artiva@San Diego@United States@2019@https://www.artivabio.com@Private@Startup@-@-@0@0@0@0@0@0@0@0@0@0@0@0@@0
Asana BioSciences@-@-@-@-@-@-@-@-@1@0@1@0@0@0@0@0@0@0@0@0@@1
Aspyrian@-@-@-@-@-@-@-@-@1@0@0@0@1@0@0@0@0@0@0@1@Rakuten Medical@0
Astellas@Tokyo@Japan@2005@https://www.astellas.com@Public@Established@Antibody developer@-@7@2@4@0@0@1@0@11@6@4@1@7@Roche | Agensys | Seagen | Merck Sharp & Dohme | Ganymed | GILEAD | Ligand Pharmaceuticals@22
AstraZeneca@Cambridge@United Kingdom@1999@https://www.astrazeneca.com@Public@Established@Antibody developer@-@12@0@6@3@1@1@1@76@11@34@29@17@ADC Therapeutics | Innate | Fusion Pharmaceuticals Inc | Eisai | DAIICHI SANKYO | NSABP Foundation | KYM Biosciences | MedImmune | NeoTX Therapeutics Ltd | Keymed Biosciences | Lepu Biopharma | Open Innovation Partners | Tanabe Research Laboratories USA | Natera | Merck Sharp & Dohme | GILEAD | Paxman Coolers Limited@72
Bayer@Leverkusen@Germany@1863@https://www.bayer.com@Public@Established@Antibody developer@-@6@0@4@1@1@0@0@12@10@2@0@2@IMMUNOGEN | MorphoSys AG@73
BeiGene@Beijing@China@2010@https://www.beigene.com@Public@Startup@Unclear@-@3@0@2@1@0@0@0@5@2@3@0@4@Jiangsu HengRui Medicine | Takeda | RemeGen | Zymeworks@3
BiOneCure Therapeutics Inc@-@-@-@-@-@-@-@-@1@0@0@1@0@0@0@1@0@1@0@0@@1
Bicycle Therapeutics@Cambridge@United Kingdom@2009@https://bicycletherapeutics.com/@Public@Startup@ADC Platform Technology Technology@-@1@1@0@0@0@0@0@0@0@0@0@0@@0
Bio thera Solutions@Guangzhou@China@2010@https://www.biotherасolutions.com@Public@Startup@Antibody developer@-@5@0@3@0@1@0@1@1@1@0@0@0@@1
BioAtla@San Diego@United States@2007@https://www.bioatla.com@Public@Startup@Unclear@-@2@0@0@2@0@0@0@4@0@4@0@1@Sinobioway Biomedicine@8
BioNTech@Mainz@Germany@2008@https://biontech.de@Public@Startup@-@-@0@0@0@0@0@0@0@1@0@0@1@1@Duality Biologics@0
BioRay@-@-@-@-@-@-@-@-@1@0@1@0@0@0@0@0@0@0@0@0@@0
BioTest@Dreieich@Germany@-@https://www.biotest.com@Public@Established@Antibody Developer@-@1@0@0@1@0@0@0@2@0@2@0@1@IMMUNOGEN@1
Biocytogen@Beijing@China@2009@https://www.biocytogen.com@Private@Startup@Unclear@-@3@2@0@1@0@0@0@0@0@0@0@2@RemeGen | MabPlex@1
Biogen@Cambridge@United States@1978@https://www.biogen.com@Public@Established@Unclear@-@2@0@1@0@0@0@1@1@1@0@0@1@Schering@1
Biohaven@New Haven@United States@2013@https://www.biohavenpharma.com@Public@Startup@Unclear@Acquired by Pfizer in 2022@3@2@0@1@0@0@0@1@0@1@0@0@@1
Biosion (China)@Nanjing@China@-@https://www.biosion.com@Private@Startup@Antibody Developer@-@1@0@0@1@0@0@0@0@0@0@0@1@OBI Pharma@1
Bliss (Hangzhou)@Hangzhou@China@2018@-@Private@Startup@Unclear@-@3@0@1@2@0@0@0@3@2@1@0@1@Eisai@3
Boehringer Ingelheim@Ingelheim am Rhein@Germany@1885@https://www.boehringer-ingelheim.com/@Private@Established@Antibody Developer, ADC Platform Technology@-@1@0@1@0@0@0@0@3@2@1@0@1@IMMUNOGEN@0
Bolt@Cambridge@United States@2015@https://www.boltbio.com/@Private@Startup@Antibody Developer@-@1@0@0@0@1@0@0@2@0@2@0@2@Bristol Myers Squibb | Roche@72
Bristol Myers Squibb@New York City@United States@1887@https://www.bms.com@Public@Established@Antibody developer@-@6@0@1@4@1@0@0@13@2@11@0@8@Celgene | Eisai | CytomX | Sutro Biopharma | Seagen | Bolt | GILEAD | Medarex@54
Byondis@Nijmegen@Netherlands@2012@https://www.byondis.com@Private@Startup@ADC platform technology@-@4@0@3@0@1@0@0@7@5@1@1@1@Synthon Pharmaceuticals Durham, NC@58
CSPC Pharmaceutical Group@Shijiazhuang@China@1986@https://www.cspc.com.cn@Public@Established@Unclear@-@3@0@2@0@1@0@0@3@1@1@1@2@Elevation Oncology | Corbus@4
CStone Pharmaceuticals@Suzhou@China@2015@https://www.cstonepharma.com/@Public@Startup@Antibody Developer@-@1@0@1@0@0@0@0@1@1@0@0@0@@3
Cambridge Antibody Technology@Cambridge@United Kingdom@1989@-@Public@Established@Antibody developer@Acquired by AstraZeneca in 2006@0@0@0@0@0@0@0@1@1@0@0@1@MedImmune@0
Caris Life Sciences@Irving@United States@2008@https://www.carislifesciences.com@Private@Established@-@-@0@0@0@0@0@0@0@0@0@0@0@0@@0
Catalent@Somerset@United States@2007@https://www.catalent.com/@Public@Established@ADC Platform Technology@-@1@0@1@0@0@0@0@0@0@0@0@1@Triphase Accelerator Corporation@2
Celgene@Summit@United States@1986@https://www.celgene.com/@Public@Established@-@Acquired by Bristol-Myers Squibb in 2019@1@0@0@1@0@0@0@6@4@2@0@5@Novartis | Sutro Biopharma | Bristol Myers Squibb | Seagen | Pfizer@5
Celldex@Hampton@United States@1983@https://www.celldex.com@Public@Established@Unclear@-@2@0@0@1@1@0@0@2@0@2@0@0@@9
Cellerant Therapeutics@San Carlos@United States@2003@https://www.cellerant.com/@Private@Startup@-@-@1@0@1@0@0@0@0@0@0@0@0@0@@0
Celltech@Slough@United Kingdom@1980@-@Public@Established@Antibody Developer@Acquired by UCB in 2004@1@0@0@1@0@0@0@0@0@0@0@2@Pfizer | WYETH@0
Centrose@Madison@United States@2004@https://www.centrose.com@Private@Startup@Unclear@-@2@2@0@0@0@0@0@0@0@0@0@1@Wisconsin Alumni Research Foundation - WARF@0
Chiatai Tianqing@Nanjing@China@1992@https://www.ctgpharma.com/@Public@Established@-@-@1@0@0@1@0@0@0@6@3@3@0@0@@1
Chiron Pharma@Emeryville@United States@1981@-@Public@Established@-@Acquired by Novartis in 2006@0@0@0@0@0@0@0@0@0@0@0@0@@0
Chugai@Tokyo@Japan@1925@https://www.chugai-pharm.co.jp@Public@Established@-@-@0@0@0@0@0@0@0@2@0@0@2@1@Roche@0
Clovis Oncology@Boulder@United States@2009@https://www.clovisoncology.com@Public@Startup@-@-@0@0@0@0@0@0@0@1@1@0@0@1@IMMUNOGEN@0
Coherent Biopharma@-@-@-@-@-@-@-@-@0@0@0@0@0@0@0@0@0@0@0@0@@0
Concortis@San Diego@United States@2008@-@Private@Startup@Antibody Platform Technology@-@3@2@0@0@0@0@1@0@0@0@0@1@Zova Biotherapeutics@0
Conjugate Light (Australia) Pty Ltd@Melbourne@Australia@-@-@Private@-@-@-@0@0@0@0@0@0@0@1@1@0@0@0@@0
Conjupro Biotherapeutics@-@-@-@-@-@-@-@-@0@0@0@0@0@0@0@1@1@0@0@0@@0
Corbus@Norwood@United States@2009@https://www.corbuspharma.com/@Public@Startup@-@-@1@0@0@1@0@0@0@1@0@1@0@1@CSPC Pharmaceutical Group@4
CuraGen Corporation@Branford@United States@1992@-@Public@Established@-@Acquired by Celldex Therapeutics in 2009@0@0@0@0@0@0@0@2@0@2@0@0@@0
CureMeta@Cambridge@United States@2020@https://www.curemeta.com/@Private@Startup@Antibody Developer@-@1@1@0@0@0@0@0@0@0@0@0@0@@0
Cytogen@Princeton@United States@1980@-@Public@Established@-@Acquired by EUSA Pharma in 2008@0@0@0@0@0@0@0@0@0@0@0@0@@0
Cytoguide ApS@Copenhagen@Denmark@2015@https://www.cytoguide.com/@Private@Startup@Antibody Developer@-@1@1@0@0@0@0@0@0@0@0@0@0@@0
CytomX@South San Francisco@United States@2008@https://www.cytomx.com@Public@Startup@ADC platform technology@-@5@0@0@5@0@0@0@1@0@1@0@3@IMMUNOGEN | Bristol Myers Squibb | AbbVie@4
DAIICHI SANKYO@Tokyo@Japan@2005@https://www.daiichisankyo.com@Public@Established@Antibody developer@-@8@0@2@1@4@1@0@72@12@33@26@10@Translational Research in Oncology | AstraZeneca | Amgen | Eisai | NSABP Foundation | UNICANCER | Merck Sharp & Dohme | MedSIR | GILEAD | Paxman Coolers Limited@68
Debiopharm@Lausanne@Switzerland@1980@https://www.debiopharm.com/@Private@Established@-@-@1@0@0@1@0@0@0@0@0@0@0@1@IMMUNOGEN@0
Dendreon@Seattle@United States@1992@-@Public@Established@-@Acquired by Sanpower Group in 2017@0@0@0@0@0@0@0@1@0@1@0@0@@0
Dizal@Shanghai@China@2015@https://www.dizalpharma.com@Private@Startup@-@-@0@0@0@0@0@0@0@0@0@0@0@0@@0
Dragonfly@Waltham@United States@2015@https://www.dragonflyimmune.com@Private@Startup@-@-@0@0@0@0@0@0@0@1@0@1@0@0@@0
Duality Biologics@Hangzhou@China@2019@https://www.dualitybio.com@Private@Startup@Unclear@-@2@0@0@0@1@0@1@1@0@0@1@1@BioNTech@0
EDDC (Experimental Drug Development Centre), A*STAR Research Entities@Singapore@Singapore@-@https://www.a-star.edu.sg/eddc@Non-profit@Established@-@-@1@0@1@0@0@0@0@1@1@0@0@0@@2
EMD Serono@Rockland@United States@1919@https://www.emdserono.com/@Public@Established@-@-@2@0@1@0@1@0@0@3@2@1@0@3@GILEAD | Merck KGaA, Darmstadt, Germany | Nektar Therapeutics@24
Eisai@Tokyo@Japan@1941@https://www.eisai.com@Public@Established@Unclear@-@3@1@0@1@1@0@0@6@0@6@0@8@AstraZeneca | DAIICHI SANKYO | Bliss (Hangzhou) | NanoCarrier (Japan) | Bristol Myers Squibb | Morphotek | GILEAD | Paxman Coolers Limited@28
Elevation Oncology@New York City@United States@2019@https://www.elevationoncology.com@Private@Startup@Unclear@-@2@0@2@0@0@0@0@1@1@0@0@1@CSPC Pharmaceutical Group@2
Eli Lilly@Indianapolis@United States@1876@https://www.lilly.com@Public@Established@Antibody developer@-@4@0@4@0@0@0@0@5@4@1@0@4@Alliance Foundation Trials | Loxo Oncology | Pfizer | Genentech@4
Emergence@Waltham@United States@2020@https://www.emergencebio.com/@Private@Startup@Antibody Developer@-@1@1@0@0@0@0@0@0@0@0@0@0@@0
Endocyte@West Lafayette@United States@1995@-@Public@Established@Unclear@Acquired by Novartis in 2018@4@1@1@0@0@1@1@0@0@0@0@3@Novartis | Nordic Nanovector | Merck Sharp & Dohme@1
Enliven@-@-@-@-@-@-@-@-@0@0@0@0@0@0@0@1@1@0@0@0@@0
Enzon@Piscataway@United States@1981@-@Public@Established@ADC Platform Technology technology@Divested its specialty pharmaceutical business in 2012@0@0@0@0@0@0@0@0@0@0@0@0@@0
Esperance@Waltham@United States@2015@https://www.esperancepharma.com/@Private@Startup@Antibody Developer@-@1@0@0@0@0@0@1@0@0@0@0@0@@0
EuPAL@-@-@-@-@-@-@-@-@0@0@0@0@0@0@0@1@0@0@1@3@Genentech | AbbVie | Roche@0
Exelixis@Alameda@United States@1994@https://www.exelixis.com/@Public@Established@-@-@1@0@1@0@0@0@0@2@2@0@0@2@Iconic | Zymeworks@9
Formation Biologics (Forbius)@Toronto@Canada@2012@https://www.forbius.com@Private@Startup@Unclear@-@2@1@0@1@0@0@0@0@0@0@0@0@@1
Fortis Therapeutics@San Diego@United States@2020@https://fortistx.com/@Private@Startup@Antibody Developer@-@1@0@0@1@0@0@0@3@2@1@0@0@@1
Fudan-Zhangjiang@Shanghai@China@2015@-@Private@Startup@ADC platform technology@Need clarification on company name@4@0@3@1@0@0@0@5@4@1@0@0@@1
Fusion Pharmaceuticals Inc@Hamilton@Canada@2014@https://fusionpharma.com/@Public@Startup@Antibody Developer@-@1@0@0@1@0@0@0@1@1@0@0@1@AstraZeneca@2
G1 Therapeutics@Research Triangle Park@United States@2008@https://www.g1therapeutics.com@Public@Startup@-@-@0@0@0@0@0@0@0@1@0@1@0@0@@0
GILEAD@Foster City@United States@1987@https://www.gilead.com@Public@Established@Unclear@-@1@0@0@0@0@1@0@62@10@39@13@25@Novartis | Alliance Foundation Trials | UNICANCER | Varian Inc | EMD Serono | MFAR | Merck KGaA, Darmstadt, Germany | Arcus | Nektar Therapeutics | Eisai | NSABP Foundation | Roche | Array BioPharma | Seagen | Merck Sharp & Dohme | MedSIR | Pfizer | Paxman Coolers Limited | AstraZeneca | DAIICHI SANKYO | GOG Foundation | Bristol Myers Squibb | Immunomedics | Strata Oncology | Astellas@46
GOG Foundation@Philadelphia@United States@1970@https://gog.org/@Non-Profit@Established@-@-@2@0@0@0@2@0@0@6@0@2@4@7@Genmab | IMMUNOGEN | Roche | Sutro Biopharma | Seagen | Merck Sharp & Dohme | GILEAD@54
GWT-TUD GmbH@Dresden@Germany@-@https://www.gwt-tud.de@Private@-@-@-@0@0@0@0@0@0@0@1@0@0@1@1@Roche@0
GamaMabs@Toulouse@France@2008@https://www.gamamabs.com/@Private@Startup@Antibody Developer@-@1@0@0@0@0@0@1@0@0@0@0@0@@0
Ganymed@Mainz@Germany@2001@-@Private@Startup@Unclear@Acquired by Astellas Pharma in 2016@2@2@0@0@0@0@0@0@0@0@0@1@Astellas@0
GeneQuantum (Suzhou, China)@Suzhou@China@2015@https://www.genequantum.com@Private@Startup@ADC platform technology@-@10@4@1@2@0@0@3@4@2@2@0@1@Pyramid Biosciences@3
Genentech@South San Francisco@United States@1976@https://www.gene.com@Public@Established@Antibody developer@Acquired by Roche in 2009@16@1@8@4@0@2@1@32@7@23@2@8@AbbVie | Alliance Foundation Trials | Istari Oncology | Roche | Eli Lilly | Seagen | EuPAL | Pfizer@73
Genitope Corporation@Redwood City@United States@1995@-@Public@Established@-@Acquired by Genitope Pharmaceuticals in 2008@0@0@0@0@0@0@0@1@0@1@0@0@@0
Genmab@Copenhagen@Denmark@1999@https://www.genmab.com@Public@Established@Antibody developer@-@3@0@0@2@0@1@0@18@0@8@10@5@AbbVie | GOG Foundation | Seagen | Merck Sharp & Dohme | ADC Therapeutics@36
Genta@Berkeley Heights@United States@1981@-@Public@Established@-@Acquired by Genasense in 2009@0@0@0@0@0@0@0@1@0@1@0@0@@0
Genzyme@Cambridge@United States@1981@https://www.sanofi.com/@Public@Established@-@Acquired by Sanofi in 2011@1@1@0@0@0@0@0@0@0@0@0@0@@0
Georgetown Translational (Oxis Biotech)@Los Angeles@United States@2015@https://www.oxisbiotech.com/@Private@Startup@Antibody Developer@-@1@0@0@1@0@0@0@0@0@0@0@0@@1
GlaxoSmithKline@Brentford@UK@2000@https://www.gsk.com@Public@Established@Unclear@-@3@0@1@1@0@1@0@22@3@10@8@8@Amgen | Novartis | IMMUNOGEN | Sanofi | Roche | Mersana | Seagen | Pfizer@30
Halozyme@San Diego@United States@1998@https://www.halozyme.com/@Public@Established@ADC Platform Technology@-@1@1@0@0@0@0@0@0@0@0@0@0@@0
Hangzhou DAC Biotechnology Co., Ltd@Hangzhou@China@2015@https://www.dacbio.com/@Private@Startup@Antibody Developer@-@1@0@1@0@0@0@0@1@1@0@0@0@@0
Hangzhou Zhongmei Huadong@Hangzhou@China@-@-@Private@-@-@-@0@0@0@0@0@0@0@1@0@0@1@0@@0
Heading Medicine@-@-@-@-@-@-@-@-@0@0@0@0@0@0@0@0@0@0@0@0@@0
Heidelberg Pharma@Ladenburg@Germany@1997@https://www.heidelberg-pharma.com@Public@Established@ADC platform technology@-@4@2@0@2@0@0@0@0@0@0@0@3@MabVax | Wilex | Magenta@0
Helix BioPharma@Aurora@Canada@1994@https://www.helixbiopharma.com/@Public@Established@Antibody Developer@-@1@0@0@0@1@0@0@3@0@2@1@2@Pharm-Olam International | Theradex@2
Holy Stone Healthcare Co., Ltd@Taipei@Taiwan@1991@https://www.holystonehealth.com/@Public@Established@-@-@1@0@0@1@0@0@0@1@0@1@0@0@@0
IATRICa Inc@Sunnyvale@United States@2015@https://iatrica.com/@Private@Startup@Antibody Developer@-@1@0@0@0@1@0@0@0@0@0@0@0@@72
ICON plc@Dublin@Ireland@1990@https://www.iconplc.com@Public@Established@-@-@0@0@0@0@0@0@0@1@0@1@0@1@Miltenyi Biomedicine GmbH@0
IDEAYA@South San Francisco@United States@2015@https://www.ideayabio.com@Public@Startup@-@-@0@0@0@0@0@0@0@1@1@0@0@0@@0
IMMUNOGEN@Waltham@United States@1981@https://www.immunogen.com@Public@Established@ADC platform technology@-@22@1@6@10@2@1@2@25@8@13@4@13@Boehringer Ingelheim | Novartis | MacroGenics | CytomX | GlaxoSmithKline | Sanofi | GOG Foundation | BioTest | Debiopharm | Clovis Oncology | Merck Sharp & Dohme | MorphoSys AG | Bayer@46
Iconic@Waltham@United States@2013@https://www.iconictx.com/@Private@Startup@Antibody Developer@-@1@0@1@0@0@0@0@3@1@2@0@2@Exelixis | Zymeworks@9
Igenica@Burlingame@United States@2008@-@Private@Startup@Unclear@Acquired by Xencor in 2015@2@1@0@0@0@0@1@0@0@0@0@0@@0
Iksuda@Newcastle upon Tyne@United Kingdom@2015@https://www.iksuda.com@Private@Startup@ADC platform technology@-@4@0@1@0@0@0@3@1@1@0@0@0@@1
Immune Tolerance Network (ITN)@-@United States@-@https://www.immunetolerance.org@Non-profit@Established@-@-@0@0@0@0@0@0@0@1@0@1@0@2@Seagen | PPD@0
ImmunityBio@Culver City@United States@2015@https://www.immunitybio.com@Public@Startup@-@-@0@0@0@0@0@0@0@0@0@0@0@0@@0
ImmunoBiochem@Hangzhou@China@2020@-@Private@Startup@Unclear@-@2@2@0@0@0@0@0@0@0@0@0@0@@0
Immunomedics@Morris Plains@United States@1986@-@Public@Established@Antibody developer@Acquired by Gilead Sciences in 2020@7@0@0@1@3@1@2@0@0@0@0@1@GILEAD@59
Inhibrx@La Jolla@United States@2010@https://www.inhibrx.com/@Public@Startup@Antibody Developer@-@1@0@1@0@0@0@0@0@0@0@0@0@@0
Innate@Marseille@France@1999@https://www.innate-pharma.com/@Public@Established@Antibody Developer@-@1@0@0@0@0@0@1@0@0@0@0@1@AstraZeneca@0
Innovent@Suzhou@China@2011@https://www.innoventbio.com@Public@Established@-@-@0@0@0@0@0@0@0@0@0@0@0@0@@0
Istari Oncology@Durham@United States@2017@https://www.istarioncology.com@Private@Startup@-@-@0@0@0@0@0@0@0@1@1@0@0@1@Genentech@0
Jazz Pharmaceuticals@Dublin@Ireland@2003@https://www.jazzpharma.com@Public@Established@-@-@0@0@0@0@0@0@0@1@1@0@0@0@@0
Jiangsu HengRui Medicine@Lianyungang@China@1970@https://www.hrs.com.cn@Public@Established@Unclear@-@2@0@0@1@0@0@1@4@1@1@2@2@BeiGene | RemeGen@1
Johnson & Johnson@New Brunswick@United States@1886@https://www.jnj.com@Public@Established@Antibody developer, ADC Platform Technology technology@-@0@0@0@0@0@0@0@1@1@0@0@1@Ambrx@0
KLUS@Hangzhou@China@2018@-@Private@Startup@Unclear@-@3@0@1@1@1@0@0@2@0@2@0@0@@33
KYM Biosciences@Hangzhou@China@2019@https://www.kymbiosciences.com/@Private@Startup@Antibody Developer@-@1@0@0@1@0@0@0@0@0@0@0@3@Lepu Biopharma | AstraZeneca | Keymed Biosciences@16
Kanisa@-@-@-@-@-@-@-@-@0@0@0@0@0@0@0@1@0@1@0@0@@0
Keymed Biosciences@Chengdu@China@2016@https://www.keymedbio.com/@Public@Startup@Antibody Developer@-@1@0@0@1@0@0@0@0@0@0@0@3@Lepu Biopharma | AstraZeneca | KYM Biosciences@16
Kirilys Therapeutics@-@-@-@-@-@-@-@-@0@0@0@0@0@0@0@1@1@0@0@0@@0
Knoll (Europe)@Ludwigshafen@Germany@1886@https://www.knoll.basf.com/@Public@Established@-@Acquired by BASF in 1990@1@0@0@0@0@1@0@0@0@0@0@1@Lonza Biologics@2
Kodiak Sciences@Palo Alto@United States@2009@https://www.kodiak.com/@Public@Startup@Antibody Developer@-@1@0@0@0@1@0@0@2@0@0@2@0@@12
Kolltan@New Haven@United States@2008@-@Private@Startup@Unclear@Acquired by Celldex Therapeutics in 2016@2@2@0@0@0@0@0@0@0@0@0@0@@0
Kura Oncology@La Jolla@United States@2014@https://kuraoncology.com@Public@Startup@-@-@0@0@0@0@0@0@0@1@1@0@0@0@@0
Kyowa Kirin@Tokyo@Japan@1949@https://www.kyowakirin.com@Public@Established@-@-@0@0@0@0@0@0@0@1@1@0@0@1@Seagen@0
LaNova@Shanghai@China@2015@https://www.lanovabio.com/@Private@Startup@Antibody Developer@-@1@0@0@1@0@0@0@0@0@0@0@1@Turning Point therapeutics@0
Legochem@Daejeon@South Korea@2002@https://www.legochembio.com@Public@Established@Antibody Platform Technology@-@7@0@0@1@1@0@5@1@0@1@0@7@AntibodyChem Biosciences | Seasun Biomaterials | Y-Biologics | Takeda | Samsung Medical Center | Nordic Nanovector | Shanghai Fosun@72
Lepu Biopharma@Beijing@China@2020@https://www.lepubiopharma.com@Private@Startup@Unclear@-@3@0@0@2@1@0@0@0@0@0@0@4@AstraZeneca | KYM Biosciences | Shanghai Miracogen | Keymed Biosciences@17
Ligand Pharmaceuticals@San Diego@United States@1987@https://www.ligand.com/@Public@Established@ADC Platform Technology@-@1@0@1@0@0@0@0@0@0@0@0@3@Astellas | Seagen | Agensys@0
Lisata Therapeutics@Basking Ridge@United States@1980@https://lisatatx.com@Public@Established@-@-@0@0@0@0@0@0@0@1@0@1@0@0@@0
Lonza Biologics@Visp@Switzerland@1897@https://www.lonza.com/@Public@Established@ADC Platform Technology@-@1@0@0@0@0@1@0@0@0@0@0@1@Knoll (Europe)@2
Loxo Oncology@Stamford@United States@2013@-@Public@Startup@Antibody developer@Acquired by Eli Lilly in 2019@3@0@3@0@0@0@0@3@3@0@0@1@Eli Lilly@3
Luzsana Biotechnology@Hangzhou@China@2019@https://www.luzsana.com/@Private@Startup@Antibody Developer@-@1@0@0@0@1@0@0@0@0@0@0@0@@72
MBrace Therapeutics@-@-@-@-@-@-@-@-@0@0@0@0@0@0@0@1@1@0@0@0@@0
MFAR@-@-@-@-@-@-@-@-@0@0@0@0@0@0@0@1@0@1@0@1@GILEAD@0
MabPlex@San Diego@United States@2015@https://www.mabplexinc.com@Private@Startup@CDMO@-@5@0@0@4@0@1@0@0@0@0@0@3@Rongchang | Biocytogen | RemeGen@13
MabVax@San Diego@United States@2006@https://www.mabvax.com/@Public@Startup@Antibody Developer@-@1@1@0@0@0@0@0@0@0@0@0@2@Wilex | Heidelberg Pharma@0
Mabwell (Shanghai)@Shanghai@China@2016@https://www.mabwell.com/@Private@Startup@Antibody Developer@-@1@0@0@1@0@0@0@0@0@0@0@0@@0
MacroGenics@Rockville@United States@2000@https://www.macrogenics.com@Public@Established@Antibody developer@-@3@1@0@2@0@0@0@2@1@1@0@1@IMMUNOGEN@3
Magenta@Cambridge@United States@2016@https://www.magentatx.com/@Public@Startup@Antibody Developer@-@1@0@0@1@0@0@0@0@0@0@0@1@Heidelberg Pharma@0
MedImmune@Gaithersburg@United States@1988@-@Public@Established@Antibody developer@Acquired by AstraZeneca in 2007@5@0@4@0@0@0@1@9@7@1@1@5@AstraZeneca | Open Innovation Partners | Tanabe Research Laboratories USA | Cambridge Antibody Technology | ADC Therapeutics@15
MedSIR@Barcelona@Spain@-@https://www.medsir.org@Private@-@-@-@0@0@0@0@0@0@0@6@0@6@0@3@GILEAD | DAIICHI SANKYO | Roche@0
Medarex@Princeton@United States@1987@-@Public@Established@Unclear@Acquired by Bristol-Myers Squibb in 2009@2@0@1@1@0@0@0@0@0@0@0@1@Bristol Myers Squibb@1
MediLink@Hangzhou@China@2020@-@Private@Startup@Unclear@-@2@0@0@2@0@0@0@4@1@3@0@0@@2
MediaPharma@L'Aquila@Italy@2010@-@Private@Startup@Antibody developer@-@3@2@0@0@0@0@1@0@0@0@0@0@@0
Medivation@San Francisco@United States@1995@-@Public@Established@-@Acquired by Pfizer in 2016@0@0@0@0@0@0@0@1@0@1@0@0@@0
Menarini Ricerche@Florence@Italy@-@https://www.menarini.com/@Private@Established@-@-@1@0@1@0@0@0@0@0@0@0@0@1@Oxford BioTherapeutics@5
Merck KGaA, Darmstadt, Germany@Darmstadt@Germany@1668@https://www.merckgroup.com/@Public@Established@-@-@3@0@1@0@2@0@0@4@2@2@0@5@Nektar Therapeutics | VelosBio | EMD Serono | Merck Sharp & Dohme | GILEAD@24
Merck Sharp & Dohme@Kenilworth@United States@1891@https://www.msd.com@Public@Established@Unclear@-@3@0@0@0@2@0@1@32@3@21@8@14@Genmab | AstraZeneca | DAIICHI SANKYO | Endocyte | IMMUNOGEN | VelosBio | GOG Foundation | Merck KGaA, Darmstadt, Germany | RemeGen | Seagen | Strata Oncology | Astellas | Pfizer | GILEAD@54
Merrimack@Cambridge@United States@1998@https://www.merrimack.com/@Public@Established@Antibody Developer@-@1@0@0@0@1@0@0@0@0@0@0@0@@54
Mersana@Cambridge@United States@2001@https://www.mersana.com@Public@Startup@ADC platform technology@-@4@0@2@1@1@0@0@1@1@0@0@2@Takeda | GlaxoSmithKline@1
MethylGene@Montreal@Canada@1995@-@Public@Established@-@Acquired by Mirati Therapeutics in 2013@0@0@0@0@0@0@0@1@0@1@0@0@@0
Millennium@Cambridge@United States@1993@-@Public@Established@Antibody developer@Acquired by Takeda in 2008@3@0@0@3@0@0@0@23@7@12@3@3@Takeda | Seagen | Samsung Medical Center@1
Miltenyi Biomedicine GmbH@Bergisch Gladbach@Germany@-@https://www.miltenyibiotec.com@Private@-@-@-@0@0@0@0@0@0@0@1@0@1@0@1@ICON plc@0
Minghui Pharmaceutical (Hangzhou) Ltd@Hangzhou@China@-@-@Private@-@-@-@0@0@0@0@0@0@0@2@0@2@0@0@@0
Mirati Therapeutics@San Diego@United States@1995@https://www.mirati.com@Public@Established@-@-@0@0@0@0@0@0@0@1@0@0@1@0@@0
MorphoSys AG@Planegg@Germany@1992@https://www.morphosys.com/@Public@Established@Antibody Developer@-@1@0@1@0@0@0@0@1@1@0@0@2@IMMUNOGEN | Bayer@0
Morphotek@Exton@United States@2000@https://www.morphotek.com/@Private@Startup@Antibody Developer@Acquired by Eisai in 2007@1@0@0@0@1@0@0@0@0@0@0@1@Eisai@28
Multitude@Hangzhou@China@2020@-@Private@Startup@Unclear@-@2@0@2@0@0@0@0@1@1@0@0@0@@2
Mundipharma EDO@Cambridge@UK@2008@https://www.mundipharma.com@Private@Startup@Unclear@-@2@0@0@0@0@0@2@0@0@0@0@0@@0
Mythic Therapeutics@Cambridge@United States@2020@https://www.mythictx.com/@Private@Startup@Antibody Developer@-@1@0@1@0@0@0@0@1@1@0@0@0@@6
NBE Therapeutics@Basel@Switzerland@2012@https://www.nbe-therapeutics.com@Private@Startup@ADC platform technology@-@3@0@0@1@0@0@2@0@0@0@0@0@@0
NSABP Foundation@-@United States@-@https://www.nsabp.org@Non-profit@Established@-@-@0@0@0@0@0@0@0@3@0@0@3@5@AstraZeneca | DAIICHI SANKYO | Alliance Foundation Trials | Roche | GILEAD@0
NanoCarrier (Japan)@Chiba@Japan@1996@https://www.nanocarrier.co.jp/@Public@Established@ADC Platform Technology@-@1@1@0@0@0@0@0@0@0@0@0@1@Eisai@0
NanoValent@Waltham@United States@2015@https://www.nanovalent.com@Private@Startup@ADC platform technology@-@3@0@0@1@2@0@0@0@0@0@0@0@@58
Natera@Austin@United States@2004@https://www.natera.com@Public@Established@-@-@0@0@0@0@0@0@0@1@0@1@0@1@AstraZeneca@0
Nektar Therapeutics@San Francisco@United States@1990@https://www.nektar.com@Public@Established@ADC Platform Technology technology@-@0@0@0@0@0@0@0@1@0@1@0@3@GILEAD | Merck KGaA, Darmstadt, Germany | EMD Serono@0
NeoTX Therapeutics Ltd@Jerusalem@Israel@2015@https://www.neotx.com/@Private@Startup@-@-@0@0@0@0@0@0@0@2@1@1@0@2@Translational Drug Development | AstraZeneca@0
Nerviano Medical Sciences@Nerviano@Italy@1963@https://www.nervianoms.com/@Private@Established@-@-@0@0@0@0@0@0@0@0@0@0@0@0@@0
Neuronix Ltd@Yokneam@Israel@2009@https://www.neuronixmedical.com/@Private@Startup@-@-@0@0@0@0@0@0@0@1@0@0@0@1@company: K The Power@0
Nona Bioscience@Suzhou@China@2015@https://www.nonabio.com/@Private@Startup@Antibody Developer@-@1@0@0@0@0@0@1@0@0@0@0@1@Pfizer@0
NordForsk@Oslo@Norway@2005@https://www.nordforsk.org/@Non-Profit@Established@-@-@0@0@0@0@0@0@0@1@0@0@1@4@Nova Laboratories Limited | Pfizer | Amgen | Servier@0
Nordic Nanovector@Oslo@Norway@2009@https://www.nordicnanovector.com@Public@Startup@ADC platform technology@-@3@0@0@1@0@1@1@1@0@1@0@4@Endocyte | Y-Biologics | Novartis | Legochem@24
Nova Laboratories Limited@Leicester@United Kingdom@1984@https://www.novalabs.co.uk/@Private@Established@-@-@0@0@0@0@0@0@0@1@0@0@1@4@Amgen | Pfizer | Servier | NordForsk@0
Novartis@Basel@Switzerland@1996@https://www.novartis.com@Public@Established@Antibody developer@-@6@0@4@0@1@1@0@8@4@2@2@7@Celgene | Endocyte | IMMUNOGEN | GlaxoSmithKline | GILEAD | Pfizer | Nordic Nanovector@11
Novavax@Gaithersburg@United States@1987@https://www.novavax.com/@Public@Established@-@-@0@0@0@0@0@0@0@1@1@0@0@0@@0
NovoCure Ltd@St. Helier@Jersey@2000@https://www.novocure.com/@Public@Startup@-@-@0@0@0@0@0@0@0@1@1@0@0@0@@0
OBI Pharma@Taipei@Taiwan@2002@https://www.obipharma.com@Public@Startup@Unclear@-@2@0@0@2@0@0@0@1@0@1@0@1@Biosion (China)@1
OnCusp Therapeutics@San Francisco@United States@2020@https://www.oncusptx.com/@Private@Startup@Antibody Developer@-@1@0@1@0@0@0@0@1@1@0@0@0@@1
Onco-Pharmakon Inc@Montreal@Canada@2015@https://onco-pharmakon.com/@Private@Startup@Antibody Developer@-@1@1@0@0@0@0@0@0@0@0@0@0@@0
OncoTherapy Science (Japan)@Tokyo@Japan@2001@https://www.oncotherapy.co.jp/@Public@Established@Antibody Developer@-@1@0@1@0@0@0@0@0@0@0@0@0@@0
Oncolinx@Boston@United States@2015@https://www.oncolinx.com/@Private@Startup@ADC Platform Technology@-@1@1@0@0@0@0@0@0@0@0@0@0@@0
Oncomatryx@Bilbao@Spain@2011@-@Private@Startup@Unclear@-@2@1@1@0@0@0@0@1@1@0@0@0@@2
Open Innovation Partners@Boston@United States@2015@https://openinnovationpartners.com/@Private@Startup@-@-@1@0@1@0@0@0@0@1@1@0@0@3@AstraZeneca | MedImmune | Tanabe Research Laboratories USA@1
Orano Med LLC@Rockville@United States@-@https://www.oranomed.com/@-@-@-@-@0@0@0@0@0@0@0@1@1@0@0@0@@0
Orum Therapeutics USA, Inc@San Francisco@United States@2018@https://www.orumtx.com/@Private@Startup@Antibody Developer@-@1@0@1@0@0@0@0@1@1@0@0@0@@1
Oxford BioMedica@Oxford@United Kingdom@1995@https://www.oxfordbiomedica.co.uk/@Public@Established@Viral Vector Platform@-@1@0@0@1@0@0@0@0@0@0@0@2@Pfizer | WYETH@1
Oxford BioTherapeutics@Oxford@United Kingdom@2004@https://www.oxfordbiotherapeutics.com/@Private@Startup@Antibody Developer@-@1@0@1@0@0@0@0@1@1@0@0@1@Menarini Ricerche@5
PPD@Wilmington@United States@1985@https://www.ppd.com/@Public@Established@-@Acquired by Thermo Fisher Scientific in 2021@0@0@0@0@0@0@0@1@0@1@0@2@Immune Tolerance Network (ITN) | Seagen@0
PT AIVITA Biomedika Indonesia@Jakarta@Indonesia@-@-@-@-@-@-@0@0@0@0@0@0@0@2@1@1@0@1@Aivita Biomedical@0
PT. Prodia Stem Cell Indonesia@Jakarta@Indonesia@-@-@-@-@-@-@0@0@0@0@0@0@0@1@0@1@0@0@@0
Palleos Healthcare GmbH@-@-@-@-@-@-@-@-@0@0@0@0@0@0@0@1@0@0@0@1@mobile Health AG@0
Paxman Coolers Limited@Huddersfield@United Kingdom@1969@https://paxmanscalpcooling.com/@Private@Established@-@-@0@0@0@0@0@0@0@1@0@1@0@4@AstraZeneca | GILEAD | DAIICHI SANKYO | Eisai@0
Peregrine Pharmaceuticals@Tustin@United States@1981@https://www.peregrineinc.com/@Public@Established@Antibody Developer@-@1@0@0@0@0@0@1@0@0@0@0@0@@0
Pfizer@New York City@United States@1849@https://www.pfizer.com@Public@Established@Antibody developer@-@14@1@4@3@1@2@3@51@13@27@6@25@AbbVie | Novartis | Alliance Foundation Trials | GlaxoSmithKline | Nona Bioscience | Eli Lilly | Rinat | Amgen | Roche | Array BioPharma | Seagen | Merck Sharp & Dohme | NordForsk | Stemcentrx | GILEAD | Celgene | UCB Pharma | Genentech | WYETH | Servier | Oxford BioMedica | Angiex | Nova Laboratories Limited | Strata Oncology | Celltech@39
Pharm-Olam International@Houston@United States@1994@https://www.pharm-olam.com/@Private@Established@-@-@1@0@0@0@1@0@0@1@0@1@0@1@Helix BioPharma@2
PharmaMar@Madrid@Spain@1986@https://pharmamar.com/@Public@Established@-@-@1@1@0@0@0@0@0@0@0@0@0@0@@0
Pheon Therapeutics@-@-@-@-@-@-@-@-@0@0@0@0@0@0@0@1@1@0@0@0@@0
Pierre Fabre@Castres@France@1961@https://www.pierre-fabre.com/@Private@Established@-@-@1@0@0@1@0@0@0@1@0@1@0@1@Roche@2
Precision Life Sciences Group@-@-@-@-@-@-@-@-@0@0@0@0@0@0@0@2@1@1@0@0@@0
Prima BioMed Ltd@Sydney@Australia@1997@https://www.primabiomed.com.au/@Public@Established@-@-@0@0@0@0@0@0@0@2@0@2@0@0@@0
ProfoundBio@Suzhou@China@2019@https://www.profoundbio.com@Private@Startup@Unclear@-@2@0@0@1@0@0@1@1@0@1@0@0@@2
Progenics Pharmaceuticals@New York City@United States@1986@-@Public@Established@Antibody developer@Acquired by Lantheus in 2019@4@0@0@3@1@0@0@5@2@3@0@1@Ambrx@1
Puma Biotechnology, Inc@Los Angeles@United States@2010@https://www.pumabiotechnology.com/@Public@Startup@-@-@0@0@0@0@0@0@0@2@1@1@0@0@@0
Pyramid Biosciences@Boston@United States@2018@https://pyramidbio.com/@Private@Startup@Antibody Developer@-@1@0@0@1@0@0@0@0@0@0@0@1@GeneQuantum (Suzhou, China)@1
Pyxis Oncology@Cambridge@United States@2018@https://www.pyxisoncology.com/@Public@Startup@Antibody Developer@-@1@0@1@0@0@0@0@0@0@0@0@0@@0
Radiation Therapy Oncology Group@-@-@-@https://www.rtog.org/@Non-Profit@Established@-@-@0@0@0@0@0@0@0@1@0@0@1@1@AbbVie@0
Rakuten Medical@Tokyo@Japan@2005@https://www.rakuten-med.com/@Private@Startup@Antibody Developer@-@1@0@0@0@1@0@0@0@0@0@0@1@Aspyrian@0
Redwood Bioscience@-@-@-@-@-@-@-@Acquired by Catalent in 2014@0@0@0@0@0@0@0@0@0@0@0@0@@0
Regeneron@Tarrytown@United States@1988@https://www.regeneron.com@Public@Established@Antibody developer@-@3@1@0@1@0@0@1@2@0@1@1@1@ADC Therapeutics@1
RemeGen@Yantai@China@2008@https://www.remegen.com@Public@Startup@Antibody developer@-@6@0@0@3@2@1@0@41@6@28@7@6@Jiangsu HengRui Medicine | BeiGene | Seagen | Merck Sharp & Dohme | Biocytogen | MabPlex@72
Rinat@South San Francisco@United States@2001@https://www.rinatcorp.com/@Private@Startup@Antibody Developer@Acquired by Pfizer in 2006@2@0@0@0@0@0@2@0@0@0@0@2@Pfizer | WYETH@0
Roche@Basel@Switzerland@1896@https://www.roche.com@Public@Established@Antibody developer@-@14@0@6@5@0@2@1@56@5@32@18@15@AbbVie | EuPAL | Bolt | NSABP Foundation | Chugai | GlaxoSmithKline | GOG Foundation | Pierre Fabre | Genentech | Seagen | MedSIR | Astellas | Pfizer | GWT-TUD GmbH | GILEAD@73
Rongchang@Chongqing@China@-@-@Private@-@-@-@1@0@0@1@0@0@0@0@0@0@0@1@MabPlex@0
SICHUAN BIOKIN@Chengdu@China@-@-@-@-@-@-@0@0@0@0@0@0@0@0@0@0@0@0@@0
SOTIO Bio@Prague@Czech Republic@2010@https://www.sotio.com/@Private@Startup@Antibody Developer@-@1@0@0@0@1@0@0@3@0@2@1@0@@5
Samsung Medical Center@Seoul@South Korea@1994@https://www.samsunghospital.com/@Public@Established@-@-@1@0@0@0@0@0@1@1@0@1@0@2@Millennium | Legochem@0
Sanofi@Paris@France@2004@https://www.sanofi.com@Public@Established@Antibody developer@-@4@0@1@2@1@0@0@11@0@5@5@2@IMMUNOGEN | GlaxoSmithKline@12
Schering@Berlin@Germany@1885@https://www.bayer.com/@Public@Established@-@Acquired by Bayer in 2006@1@0@0@0@0@0@1@0@0@0@0@1@Biogen@0
Seagen@Bothell@United States@1998@https://www.seagen.com@Public@Established@ADC platform technology@Acquired by Pfizer in 2023@22@1@10@4@3@4@0@93@21@58@12@21@Millennium | Alliance Foundation Trials | GlaxoSmithKline | Ligand Pharmaceuticals | Teva | Kyowa Kirin | Roche | Merck Sharp & Dohme | Pfizer | GILEAD | Celgene | PPD | Takeda | GOG Foundation | Agensys | Genentech | Immune Tolerance Network (ITN) | Genmab | Bristol Myers Squibb | RemeGen | Astellas@61
Seasun Biomaterials@Hangzhou@China@2014@https://www.seasunbio.com/@Private@Startup@-@-@1@0@0@0@0@0@1@0@0@0@0@1@Legochem@0
Servier@Suresnes@France@1954@https://servier.com/@Private@Established@-@-@0@0@0@0@0@0@0@1@0@0@1@4@Nova Laboratories Limited | Pfizer | Amgen | NordForsk@0
Shanghai Fosun@Shanghai@China@1994@https://www.fosunpharma.com@Public@Established@Unclear@-@2@0@0@0@2@0@0@1@0@0@1@1@Legochem@72
Shanghai Hansoh Biomedical@Shanghai@China@2004@https://www.hansohbio.com@Public@Established@Antibody developer@-@3@0@0@3@0@0@0@6@3@3@0@0@@1
Shanghai Henlius@Shanghai@China@2010@https://www.henlius.com@Public@Startup@Unclear@-@2@0@2@0@0@0@0@2@2@0@0@0@@1
Shanghai Institute Of Biological Products@Shanghai@China@-@-@Public@Established@-@-@1@0@1@0@0@0@0@1@1@0@0@0@@0
Shanghai Junshi@Shanghai@China@2012@https://www.junshipharma.com/@Public@Startup@Antibody Developer@-@1@0@1@0@0@0@0@0@0@0@0@0@@0
Shanghai Miracogen@Shanghai@China@2015@https://www.miracogen.com@Private@Startup@ADC platform technology@-@3@0@0@1@2@0@0@10@1@6@3@1@Lepu Biopharma@72
Shanghai Pharmaceuticals Holding@Shanghai@China@1994@https://www.sphchina.com/@Public@Established@-@-@1@0@1@0@0@0@0@1@1@0@0@0@@1
Shattuck Labs@Austin@United States@2016@https://www.shattucklabs.com/@Public@Startup@Antibody Developer@-@0@0@0@0@0@0@0@0@0@0@0@0@@0
Shenogen Pharma@Beijing@China@-@-@Private@-@-@-@1@1@0@0@0@0@0@0@0@0@0@0@@0
Siamab@Newton@United States@2012@https://www.siamab.com/@Private@Startup@Antibody Developer@-@1@1@0@0@0@0@0@0@0@0@0@0@@0
Sichuan Baili@Chengdu@China@-@-@Private@-@-@-@1@0@1@0@0@0@0@0@0@0@0@1@Systimmune@0
Sichuan Kelun@Chengdu@China@1992@http://www.kelunpharma.com/@Public@Established@-@-@0@0@0@0@0@0@0@1@1@0@0@0@@0
Silverback@Seattle@United States@2016@https://silverbacktx.com/@Public@Startup@Antibody Developer@-@1@0@0@0@1@0@0@0@0@0@0@0@@53
Sino Biopharmaceutical@Hong Kong@China@1997@https://www.sinobiopharm.com/@Public@Established@-@-@1@0@1@0@0@0@0@0@0@0@0@0@@1
Sinobioway Biomedicine@Beijing@China@-@-@Private@-@-@-@1@0@0@1@0@0@0@0@0@0@0@1@BioAtla@8
Sorrento Therapeutics@San Diego@United States@2006@https://www.sorrentotherapeutics.com@Public@Startup@Unclear@-@2@0@0@1@0@0@1@3@1@2@0@0@@2
Spectrum Pharmaceuticals@Henderson@United States@1987@https://www.sppirx.com/@Public@Established@-@-@0@0@0@0@0@0@0@0@0@0@0@0@@0
Spirogen@London@United Kingdom@1995@https://www.spirogen.com/@-@Established@ADC Platform Technology Technology@Acquired by AstraZeneca in 2013@0@0@0@0@0@0@0@0@0@0@0@0@@0
Stemcentrx@South San Francisco@United States@2008@-@Private@Startup@ADC platform technology@Acquired by AbbVie in 2016@4@0@1@1@1@0@1@2@1@1@0@2@Pfizer | AbbVie@36
Strata Oncology@Ann Arbor@United States@2015@https://www.strataoncology.com/@Private@Startup@-@-@0@0@0@0@0@0@0@1@0@1@0@3@GILEAD | Pfizer | Merck Sharp & Dohme@0
Sutro Biopharma@South San Francisco@United States@2003@https://www.sutrobio.com@Public@Startup@ADC platform technology@-@7@0@2@1@2@0@2@5@3@1@1@4@Tasly Pharmaceutical Group Co., Ltd | Celgene | Bristol Myers Squibb | GOG Foundation@10
Suzhou Zanrong Pharma@Suzhou@China@-@-@-@-@-@-@0@0@0@0@0@0@0@1@1@0@0@0@@0
Synthon Pharmaceuticals Durham, NC@Durham@United States@-@-@-@-@-@Acquired by Synthon Holding B.V. in 2015@1@0@0@0@1@0@0@0@0@0@0@1@Byondis@58
Systimmune@Bothell@United States@2015@https://www.systimmune.com@Private@Startup@ADC platform technology@-@4@3@1@0@0@0@0@0@0@0@0@1@Sichuan Baili@0
TG Therapeutics, Inc@New York@United States@1993@https://www.tgtherapeutics.com/@Public@Established@-@-@0@0@0@0@0@0@0@1@1@0@0@0@@0
TMC Pharma@-@-@-@-@-@-@-@-@0@0@0@0@0@0@0@1@0@0@1@1@Amphera BV@0
TORL Biotherapeutics@Irvine@United States@2021@https://www.torlbio.com@Private@Startup@ADC platform technology@-@4@0@4@0@0@0@0@4@4@0@0@1@Translational Research in Oncology@3
TOT Biopharm@Suzhou@China@2010@https://www.totbiopharm.com/@Public@Established@Antibody Developer@-@1@0@0@0@1@0@0@0@0@0@0@0@@0
Takeda@Osaka@Japan@1781@https://www.takeda.com@Public@Established@Antibody developer@-@8@0@2@4@0@1@1@12@0@7@3@5@Millennium | Mersana | BeiGene | Legochem | Seagen@38
Tallac Therapeutics@Burlingame@United States@2017@https://tallactherapeutics.com/@Private@Startup@Antibody Developer@-@1@0@0@1@0@0@0@1@0@1@0@0@@2
Tanabe Research Laboratories USA@San Diego@United States@-@https://www.tanabe-usa.com/@Private@Established@-@-@1@0@1@0@0@0@0@0@0@0@0@3@Open Innovation Partners | AstraZeneca | MedImmune@1
Targetome SA@Liège@Belgium@2015@https://www.targetome.com@Private@Startup@ADC platform technology@-@5@0@0@0@0@0@5@0@0@0@0@0@@0
Tarveda@Watertown@United States@2011@-@Private@Startup@Unclear@Acquired by Centrose in 2022@2@0@0@2@0@0@0@0@0@0@0@0@@0
Tasly Pharmaceutical Group Co., Ltd@Tianjin@China@1994@http://www.tasly.com/@Public@Established@-@-@0@0@0@0@0@0@0@1@0@1@0@1@Sutro Biopharma@0
Telix Pharmaceuticals@Melbourne@Australia@2015@https://www.telixpharma.com/@Public@Startup@-@-@0@0@0@0@0@0@0@1@1@0@0@0@@0
Teva@Petah Tikva@Israel@1901@https://www.tevapharm.com/@Public@Established@-@-@0@0@0@0@0@0@0@2@0@2@0@1@Seagen@0
Theradex@Princeton@United States@1983@https://www.theradex.com/@Private@Established@-@-@0@0@0@0@0@0@0@1@0@1@0@1@Helix BioPharma@0
Theratechnologies@Montreal@Canada@1993@https://www.theratech.com/@Public@Established@-@-@1@0@0@0@1@0@0@0@0@0@0@0@@53
Translational Drug Development@-@-@-@-@-@-@-@-@0@0@0@0@0@0@0@1@0@1@0@1@NeoTX Therapeutics Ltd@0
Translational Research in Oncology@Omaha@United States@2003@https://www.trio-cancer.org@Private@Startup@ADC platform technology@-@4@0@4@0@0@0@0@5@4@1@0@2@TORL Biotherapeutics | DAIICHI SANKYO@3
Triphase Accelerator Corporation@Toronto@Canada@2011@https://triphaseco.com/@Private@Startup@Antibody Developer@-@1@0@1@0@0@0@0@1@1@0@0@1@Catalent@2
Tubulis@Munich@Germany@2019@https://tubulis.com/@Private@Startup@ADC Platform Technology@-@1@0@0@1@0@0@0@1@0@1@0@0@@1
Turning Point therapeutics@San Diego@United States@2013@https://www.tptherapeutics.com/@Public@Startup@Antibody Developer@Acquired by Bristol Myers Squibb in 2021@1@0@0@1@0@0@0@0@0@0@0@1@LaNova@0
UCB Pharma@Brussels@Belgium@1928@https://www.ucb.com/@Public@Established@-@-@0@0@0@0@0@0@0@8@1@4@3@1@Pfizer@0
UNICANCER@Paris@France@1964@https://www.unicancer.fr/@Non-Profit@Established@-@-@0@0@0@0@0@0@0@3@0@1@2@2@GILEAD | DAIICHI SANKYO@0
Varian Inc@Palo Alto@United States@1948@https://www.varian.com/@Public@Established@-@Acquired by Siemens Healthineers in 2021@0@0@0@0@0@0@0@1@1@0@0@1@GILEAD@0
VelosBio@San Diego@United States@2017@https://velosbio.com/@Private@Startup@Antibody Developer@Acquired by Merck & Co. in 2020@1@0@0@0@1@0@0@0@0@0@0@2@Merck KGaA, Darmstadt, Germany | Merck Sharp & Dohme@0
Veru Inc.@Miami@United States@1996@https://verupharma.com/@Public@Established@-@-@0@0@0@0@0@0@0@0@0@0@0@0@@0
Vincerx Pharma, Inc@Palo Alto@United States@2017@https://vincerx.com/@Public@Startup@Antibody Developer@-@1@0@1@0@0@0@0@1@1@0@0@0@@1
Visterra@Cambridge@United States@2008@https://www.visterrainc.com/@Private@Startup@Antibody Developer@Acquired by Otsuka Pharmaceutical in 2018@1@1@0@0@0@0@0@0@0@0@0@0@@0
Vor Biopharma@Cambridge@United States@2016@https://www.vorbio.com/@Public@Startup@-@-@0@0@0@0@0@0@0@1@0@1@0@0@@0
WYETH@Madison@United States@1926@-@Public@Established@Antibody developer@Acquired by Pfizer in 2009@6@0@1@2@0@2@1@8@1@5@1@4@Rinat | Pfizer | Celltech | Oxford BioMedica@38
Westlake Therapeutics@-@United States@-@-@Private@Startup@-@-@1@0@1@0@0@0@0@1@1@0@0@0@@1
Wilex@Munich@Germany@1997@-@Public@Established@Unclear@-@2@2@0@0@0@0@0@0@0@0@0@2@MabVax | Heidelberg Pharma@0
Wisconsin Alumni Research Foundation - WARF@Madison@United States@1925@https://www.warf.org@Non-profit@Established@Unclear@-@2@2@0@0@0@0@0@0@0@0@0@1@Centrose@0
Xadcera@-@-@-@-@-@-@-@-@0@0@0@0@0@0@0@0@0@0@0@0@@0
Xenikos@Nijmegen@Netherlands@2006@https://www.xenikos.com@Private@Startup@Unclear@-@2@0@0@0@2@0@0@0@0@0@0@0@@0
Xuanzhu Biopharm@-@China@-@-@Private@Startup@-@-@1@0@1@0@0@0@0@1@1@0@0@0@@1
Y-Biologics@-@South Korea@-@https://ybiologics.com/en/@Private@Startup@Antibody Developer@-@2@0@0@0@0@0@2@0@0@0@0@2@Nordic Nanovector | Legochem@0
Zai Lab (Shanghai)@Shanghai@China@2014@https://www.zailaboratory.com/@Public@Startup@-@-@0@0@0@0@0@0@0@1@1@0@0@0@@0
Zhejiang ACEA Pharmaceutical Co. Ltd@-@-@-@-@-@-@-@-@0@0@0@0@0@0@0@1@0@1@0@0@@0
Zhejiang Medicine@Shaoxing@China@1997@https://www.zmc.top/en/@Public@Established@API & Intermediates, Human/Animal Nutrition@-@0@0@0@0@0@0@0@0@0@0@0@0@@0
ZielBio@Charlottesville@United States@-@https://www.zielbio.com@Private@Startup@Antibody Developer@-@1@0@0@1@0@0@0@0@0@0@0@0@@0
Zionexa@-@-@-@-@-@-@-@-@0@0@0@0@0@0@0@1@0@0@1@0@@0
Zova Biotherapeutics@Hangzhou@China@2020@-@Private@Startup@Unclear@-@1@0@0@0@0@0@1@0@0@0@0@1@Concortis@0
Zymeworks@Vancouver@Canada@2003@https://www.zymeworks.com@Public@Startup@Unclear@-@2@0@1@1@0@0@0@0@0@0@0@3@Exelixis | Iconic | BeiGene@10
bioRASI, LLC@-@-@-@-@-@-@-@-@0@0@0@0@0@0@0@1@0@1@0@1@Alzamend Neuro@0
company: K The Power@-@-@-@-@-@-@-@-@0@0@0@0@0@0@0@1@0@0@0@1@Neuronix Ltd@0
mobile Health AG@-@-@-@-@-@-@-@-@0@0@0@0@0@0@0@1@0@0@0@1@Palleos Healthcare GmbH@0
pharmaand GmbH@-@-@-@-@-@-@-@-@0@0@0@0@0@0@0@0@0@0@0@0@@0
